← Eichor
Condition: Hidradenitis Suppurativa Hs Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hidradenitis Suppurativa Hs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Radiotherapy for Refractory Hidradenitis Suppurativa
NA · 2 location(s) · Thomas Jefferson University · NCT07414550An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Phase 3 · 4 location(s) · Novartis Pharmaceuticals · NCT07665437Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis S
Phase 2 · 30 location(s) · Incyte Corporation · NCT07213973A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moder
Phase 2 · 2 location(s) · AbbVie · NCT06524635Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Peking Union Medical College · NCT07109765The Safety and Efficacy of Roflumilast Foam in HS
Phase 2 · 1 location(s) · Beth Israel Deaconess Medical Center · NCT07263230Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adul
Phase N/A · 16 location(s) · Novartis Pharmaceuticals · NCT07543419A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · 58 location(s) · Bluefin Biomedicine, Inc. · NCT07287644A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx®
Phase 1 · 14 location(s) · UCB Biopharma SRL · NCT06888193Real-world Secukinumab Outcomes in Canadian HS Patients
Phase N/A · 15 location(s) · Novartis Pharmaceuticals · NCT07282015Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Phase 2 · 1 location(s) · Sinocelltech Ltd. · NCT07244510A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · 41 location(s) · Navigator Medicines, Inc. · NCT07384975Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Phase 4 · 7 location(s) · Novartis Pharmaceuticals · NCT07489573A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T
Phase N/A · 10 location(s) · Sonoma Biotherapeutics, Inc. · NCT07123038Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
EARLY_Phase 1 · 1 location(s) · Virginia Clinical Research, Inc. · NCT06645821Global Healthcare Study on Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Julia Tatjana Maul · NCT07659769Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Phase 1/Phase 2 · 1 location(s) · Shanghai Huaota Biopharmaceutical Co., Ltd. · NCT06895499A Study With CIT-013 in HS Patients
Phase 2 · 28 location(s) · Citryll BV · NCT06993233A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · 285 location(s) · AbbVie · NCT05889182Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practic
Phase N/A · 4 location(s) · Novartis Pharmaceuticals · NCT067857791726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
Phase 1 · 1 location(s) · Wynn Medical Center · NCT07155239A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hid
Phase 3 · 18 location(s) · UCB Biopharma SRL · NCT06921850A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps
Phase 2 · 71 location(s) · Pfizer · NCT07228390Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Phase 3 · 318 location(s) · Incyte Corporation · NCT06855498Pelashield™ PainGuard™ vs Restrata® in HS Surgery
NA · 1 location(s) · Rutgers, The State University of New Jersey · NCT07316192SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Phase N/A · 8 location(s) · Leiden University Medical Center · NCT07021495Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Phase N/A · 1 location(s) · Peking Union Medical College · NCT06926192A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.